Detalhe da pesquisa
1.
Optimization of sub-relativistic co-propagating accelerating structures.
Opt Express
; 31(23): 38891-38909, 2023 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38017981
2.
A fragment-based approach to discovery of Receptor for Advanced Glycation End products inhibitors.
Proteins
; 89(11): 1399-1412, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34156100
3.
Monolithic AlGaAs second-harmonic nanoantennas: erratum.
Opt Express
; 29(7): 11132, 2021 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33820231
4.
Polarization properties of second-harmonic generation in AlGaAs optical nanoantennas.
Opt Lett
; 42(3): 559-562, 2017 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28146527
5.
Controlling second-harmonic generation at the nanoscale with monolithic AlGaAs-on-AlOx antennas.
Nanotechnology
; 28(11): 114005, 2017 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-28205510
6.
Monolithic AlGaAs second-harmonic nanoantennas.
Opt Express
; 24(14): 15965-71, 2016 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27410864
7.
Discovery and characterization of a novel series of N-phenylsulfonyl-1H-pyrrole picolinamides as positive allosteric modulators of the metabotropic glutamate receptor 4 (mGlu4).
Bioorg Med Chem Lett
; 26(13): 2984-2987, 2016 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27234146
8.
Discovery of 3-aminopicolinamides as metabotropic glutamate receptor subtype 4 (mGlu4) positive allosteric modulator warheads engendering CNS exposure and in vivo efficacy.
Bioorg Med Chem Lett
; 26(12): 2915-2919, 2016 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27131990
9.
R705H mutation of MYH9 is associated with MYH9-related disease and not only with non-syndromic deafness DFNA17.
Clin Genet
; 88(1): 85-9, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24890873
10.
Progress towards small molecule menin-mixed lineage leukemia (MLL) interaction inhibitors with in vivo utility.
Bioorg Med Chem Lett
; 25(13): 2720-5, 2015 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25987377
11.
Psychological treatment of obsessive compulsive disorder: an update.
Australas Psychiatry
; 23(4): 347-9, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26104776
12.
Biotransformation of a novel positive allosteric modulator of metabotropic glutamate receptor subtype 5 contributes to seizure-like adverse events in rats involving a receptor agonism-dependent mechanism.
Drug Metab Dispos
; 41(9): 1703-14, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23821185
13.
Implementation of the INTERGROWTH-21st Project in the United States.
BJOG
; 120 Suppl 2: 123-8, v, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23841827
14.
Glucose tolerance status associates with improvements in cognitive function following high-intensity exercise in adults with obesity.
Physiol Behav
; 272: 114389, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37890604
15.
Continued optimization of the MLPCN probe ML071 into highly potent agonists of the hM1 muscarinic acetylcholine receptor.
Bioorg Med Chem Lett
; 22(10): 3467-72, 2012 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22507963
16.
ER-resident proteins PDR2 and LPR1 mediate the developmental response of root meristems to phosphate availability.
Proc Natl Acad Sci U S A
; 106(33): 14174-9, 2009 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-19666499
17.
Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario.
ESMO Open
; 7(2): 100406, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35219245
18.
Sutureless aortic valves in elderly patients with aortic stenosis and intermediate-risk profile.
J Cardiovasc Med (Hagerstown)
; 22(4): 297-304, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33633045
19.
Fragment-Based Discovery of Small Molecules Bound to T-Cell Immunoglobulin and Mucin Domain-Containing Molecule 3 (TIM-3).
J Med Chem
; 64(19): 14757-14772, 2021 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34597046
20.
The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer.
ESMO Open
; 6(2): 100078, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33735802